Women who used Topamax during pregnancy and gave birth to a child with birth defects may wish to speak with an attorney to find out if they are eligible to file a lawsuit. Lawsuits filed against the manufacturers of the migraine and epilepsy drug by Topamax lawyers have alleged that patients were not properly warned that using the drug during pregnancy could increase the risk of giving birth to a child with congenital birth defects.
According to a warning by the Food and Drug Administration, women who take Topamax while pregnant are more likely to give birth to a child with cleft lip or cleft palate. Studies have also associated Topamax with an increased risk of spina bifida, persistent pulmonary hypertension of the newborn (PPHN) and other birth defects.
Based on these findings, the FDA upgraded Topamax to its Pregnancy Category D—meaning that there is strong evidence linking the drug to an increased risk of birth defects. But because birth defects such as cleft lip and cleft palate occur during the first trimester of pregnancy—a time when many women are unaware that they are pregnant—the FDA’s Topamax warning may do little to prevent birth defects among women who are already taking the drug.
If you or a loved one used Topamax while pregnant and gave birth to a child with cleft lip, cleft palate, spina bifida or other birth defects, you may be eligible to file a lawsuit. For a free legal consultation, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.